RS 67333 hydrochloride

Discontinued Product

RS 67333 hydrochloride (Cat. No. 0989) has been withdrawn from sale for commercial reasons.
Description: 5-HT4 partial agonist
Chemical Name: 1-(4-Amino-5-chloro-2-methoxyphenyl)-3-[1-butyl-4-piperidinyl]-1-propanone hydrochloride
Purity: ≥99% (HPLC)
Citations (5)
Literature (2)

Biological Activity for RS 67333 hydrochloride

RS 67333 hydrochloride is a potent and highly selective 5-HT4 partial agonist, with pKi values of 8.7 at 5-HT4 sites in guinea pig striatum and > 6 at various other receptors, including 5-HT1A, 1D, 2A, 2C, D1, D2 and M1-3. Active in vivo, with an intrinsic activity relative to 5-HT of 0.5.

Licensing Information

Sold with the permission of Roche Bioscience

Technical Data for RS 67333 hydrochloride

M. Wt 389.36
Formula C19H29ClN2O2.HCl
Storage Store at RT
Purity ≥99% (HPLC)
CAS Number 168986-60-5
PubChem ID 9800491

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for RS 67333 hydrochloride

Certificate of Analysis / Product Datasheet
Select another batch:

References for RS 67333 hydrochloride

References are publications that support the biological activity of the product.

Eglen et al (1995) Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br.J.Pharmacol. 115 1387 PMID: 8564196

Eglen et al (1995) Central 5-HT4 receptors. TiPS 16 391 PMID: 8578609

Fontana et al (1997) The effects of novel, selective 5-hydroxytryptamine (5HT)4 receptor ligands in rat spatial navigation. Neuropharmacology 36 689 PMID: 9225295

View Related Products by Target

View Related Products by Product Action

View all 5-HT4 Receptor Agonists

Keywords: RS 67333 hydrochloride, RS 67333 hydrochloride supplier, 5-HT4, partial, agonists, Serotonin, Receptors, 5-Hydroxytryptamine, RS67333, hydrochloride, 0989, Tocris Bioscience

5 Citations for RS 67333 hydrochloride

Citations are publications that use Tocris products. Selected citations for RS 67333 hydrochloride include:

Warner-Schmidt et al (2009) Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 29 1937 PMID: 19211900

Huang and Kandel (2007) Low-frequency stimulation induces a pathway-specific late phase of LTP in the amygdala that is mediated by PKA and dependent on protein synthesis. J Neurosci 14 497 PMID: 17626908

Huang and Kandel (2007) 5-Hydroxytryptamine induces a protein kinase A/mitogen-activated protein kinase-mediated and macromolecular synthesis-dependent late phase of long-term potentiation in the amygdala. Obesity (Silver Spring) 27 3111 PMID: 17376972

Eriksson et al (2013) Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Learn Mem 18 1096 PMID: 23032875

Reviews for RS 67333 hydrochloride

There are currently no reviews for this product. Be the first to review RS 67333 hydrochloride and earn rewards!

Have you used RS 67333 hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

5-HT Receptors Scientific Review

5-HT Receptors Scientific Review

Written by Nicholas M. Barnes and John F. Neumaier, this review summarizes the various serotonin receptor subtypes and their importance in mediating the role of serotonin in numerous physiological and pharmacological processes. Compounds available from Tocris are listed.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.